Irina Florentina BușIlă
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Irina Florentina BușIlă has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Alexandrina Lizica Dumitrescu
Department of Morphofunctional Sciences I, Grigore T. Popa University of Medicine and Pharmacy, Iaşi, Romania
4 shared publications - Roxana Gabriela Cobzaru
Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iași, Romania
4 shared publications - Carmen Valerica Rîpă
Grigore T. Popa University of Medicine and Pharmacy Iasi, 16 Universitatii Street, 700115 Iasi, Romania
3 shared publications - Claudia Florida Costea
Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania
3 shared publications - Lucia Corina Dima-Cozma
Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania
3 shared publications - Anca Sava2 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 17 (3) , 292-306
Neurocysticercosis in the Era of Artificial Intelligence: Neuroanatomical Insights, Neuroimaging and Predictive Computational Neurology
Neurocysticercosis (NCC), caused by the larval stage of Taenia solium, remains the most common parasitic infection of the central nervous system and a leading cause of acquired epilepsy worldwide. Despite substantial advances in neuroimaging, diagnosis and prognostic assessment remain challenging because of the heterogeneous clinical presentation and variable radiological features of the disease. Emerging developments in artificial intelligence (AI), radiomics, connectomics, and predictive computational neurology offer novel opportunities to improve diagnostic accuracy and individualised patient management. A structured literature search was conducted using PubMed, Scopus, Web of Science, and Google Scholar to identify peer-reviewed studies published between 2000 and 2025. The retrieved evidence was synthesised in a comprehensive narrative review focusing on the pathophysiology, neuroanatomical manifestations, neuroimaging characteristics and emerging computational applications in neurocysticercosis. Current evidence confirms the central role of computed tomography and magnetic resonance imaging in the diagnosis and staging of neurocysticercosis. Recent advances in radiomics, connectomics, machine learning, and deep learning demonstrate promising potential for improving lesion characterisation, differential diagnosis, quantitative imaging analysis, and prediction of neurological outcomes. Although disease-specific AI applications remain limited, computational methodologies successfully applied in neuroradiology, epilepsy, and neuro-oncology may be adapted to neurocysticercosis, supporting the development of predictive computational neurology and precision medicine. Neurocysticercosis represents a promising model for the future integration of neuroimaging, computational neuroscience, and artificial intelligence. However, current evidence remains limited by the scarcity of disease-specific datasets and the lack of large-scale clinical validation. Future multicenter studies integrating radiomics, connectomics, explainable AI, and standardised neuroimaging protocols will be essential for translating computational advances into clinically applicable diagnostic and prognostic tools capable of improving individualised neurological care.
- 16 September 2026
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 17 (3) , 292-306
Open AccessNeurocysticercosis in the Era of Artificial Intelligence: Neuroanatomical Insights, Neuroimaging and Predictive Computational Neurology
Neurocysticercosis (NCC), caused by the larval stage of Taenia solium, remains the most common parasitic infection of the central nervous system and a leading cause of acquired epilepsy worldwide. Despite substantial advances in neuroimaging, diagnosis and prognostic assessment remain challenging because of the heterogeneous clinical presentation and variable radiological features of the disease. Emerging developments in artificial intelligence (AI), radiomics, connectomics, and predictive computational neurology offer novel opportunities to improve diagnostic accuracy and individualised patient management. A structured literature search was conducted using PubMed, Scopus, Web of Science, and Google Scholar to identify peer-reviewed studies published between 2000 and 2025. The retrieved evidence was synthesised in a comprehensive narrative review focusing on the pathophysiology, neuroanatomical manifestations, neuroimaging characteristics and emerging computational applications in neurocysticercosis. Current evidence confirms the central role of computed tomography and magnetic resonance imaging in the diagnosis and staging of neurocysticercosis. Recent advances in radiomics, connectomics, machine learning, and deep learning demonstrate promising potential for improving lesion characterisation, differential diagnosis, quantitative imaging analysis, and prediction of neurological outcomes. Although disease-specific AI applications remain limited, computational methodologies successfully applied in neuroradiology, epilepsy, and neuro-oncology may be adapted to neurocysticercosis, supporting the development of predictive computational neurology and precision medicine. Neurocysticercosis represents a promising model for the future integration of neuroimaging, computational neuroscience, and artificial intelligence. However, current evidence remains limited by the scarcity of disease-specific datasets and the lack of large-scale clinical validation. Future multicenter studies integrating radiomics, connectomics, explainable AI, and standardised neuroimaging protocols will be essential for translating computational advances into clinically applicable diagnostic and prognostic tools capable of improving individualised neurological care.
- Open Access
- 3 June 2026
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 17 (2) , 423
Anxiety, Depression, and Stress in Association with Alcohol Consumption: A Cross-Sectional Study
Alcohol consumption represents a complex behavioural phenomenon influenced by multiple psychological factors. The present study aimed to examine the associations between emotional distress—specifically anxiety, depression, and stress—and alcohol consumption in a cross-sectional sample. A total of 121 participants completed standardised self-report measures, including the Depression Anxiety Stress Scales (DASS-21) and the Alcohol Use Disorders Identification Test (AUDIT). Spearman’s correlation analyses indicated that both anxiety (ρ = .203, p = .025) and depression (ρ = .219, p = .016) were positively and significantly associated with alcohol consumption, although the strength of these relationships was weak. In contrast, stress was not significantly correlated with alcohol use (ρ = .137, p = .134). A multiple regression analysis revealed that the overall model was statistically significant, F(3, 117) = 4.997, p = .003, explaining 11.4% of the variance in alcohol consumption (R² = .114). However, none of the individual predictors—anxiety, depression, or stress—demonstrated statistically significant independent effects. Additional bootstrap analyses confirmed the absence of significant effects, suggesting that the relationships observed at the correlational level did not translate into robust predictive effects. These findings highlight the nuanced role of emotional distress in alcohol consumption, suggesting that while anxiety and depression are associated with alcohol use, their predictive power may be limited when considered concurrently. The results support the importance of adopting a multidimensional perspective when examining psychological influences on alcohol-related behaviours.
- 3 June 2026
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 17 (2) , 423
Open AccessAnxiety, Depression, and Stress in Association with Alcohol Consumption: A Cross-Sectional Study
Alcohol consumption represents a complex behavioural phenomenon influenced by multiple psychological factors. The present study aimed to examine the associations between emotional distress—specifically anxiety, depression, and stress—and alcohol consumption in a cross-sectional sample. A total of 121 participants completed standardised self-report measures, including the Depression Anxiety Stress Scales (DASS-21) and the Alcohol Use Disorders Identification Test (AUDIT). Spearman’s correlation analyses indicated that both anxiety (ρ = .203, p = .025) and depression (ρ = .219, p = .016) were positively and significantly associated with alcohol consumption, although the strength of these relationships was weak. In contrast, stress was not significantly correlated with alcohol use (ρ = .137, p = .134). A multiple regression analysis revealed that the overall model was statistically significant, F(3, 117) = 4.997, p = .003, explaining 11.4% of the variance in alcohol consumption (R² = .114). However, none of the individual predictors—anxiety, depression, or stress—demonstrated statistically significant independent effects. Additional bootstrap analyses confirmed the absence of significant effects, suggesting that the relationships observed at the correlational level did not translate into robust predictive effects. These findings highlight the nuanced role of emotional distress in alcohol consumption, suggesting that while anxiety and depression are associated with alcohol use, their predictive power may be limited when considered concurrently. The results support the importance of adopting a multidimensional perspective when examining psychological influences on alcohol-related behaviours.
- Open Access
- 19 March 2026
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 17 (1) , 269-282
Brain under Parasitic Siege — A Comprehensive Descriptive Review of Neuroparasitic Diseases
Parasitic infections of the central nervous system (CNS) represent a significant yet frequently under-recognised cause of neurological morbidity and mortality worldwide. These infections are caused by a diverse range of protozoa, helminths, and free-living amoebae and may lead to acute or chronic neurological manifestations through mechanisms including direct neural invasion, immune-mediated inflammation, vascular compromise, and blood–brain barrier disruption. Clinically, neuroparasitic diseases present with a broad spectrum of symptoms, ranging from seizures and focal neurological deficits to encephalopathy, cognitive impairment, and coma. This narrative review synthesises current evidence published between 2000 and 2025 regarding the pathophysiology, clinicopathological features, diagnostic approaches, and management strategies of major neuroparasitic diseases, including cerebral malaria, neurocysticercosis, neurotoxoplasmosis, human African trypanosomiasis, and amoebic encephalitis. Emphasis is placed on integrating clinical presentation with histopathological and neuroimaging findings to support diagnostic reasoning and therapeutic decision-making. Advances in diagnostic methodologies, including molecular techniques, magnetic resonance imaging, and computed tomography are discussed, alongside emerging perspectives on the potential role of artificial intelligence (AI) in diagnostic support and epidemiological modelling. By consolidating dispersed evidence into a unified framework, this review aims to serve as an educational and interdisciplinary reference for clinicians and researchers encountering neuroparasitic diseases in neurological practice.
- 19 March 2026
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 17 (1) , 269-282
Open AccessBrain under Parasitic Siege — A Comprehensive Descriptive Review of Neuroparasitic Diseases
Parasitic infections of the central nervous system (CNS) represent a significant yet frequently under-recognised cause of neurological morbidity and mortality worldwide. These infections are caused by a diverse range of protozoa, helminths, and free-living amoebae and may lead to acute or chronic neurological manifestations through mechanisms including direct neural invasion, immune-mediated inflammation, vascular compromise, and blood–brain barrier disruption. Clinically, neuroparasitic diseases present with a broad spectrum of symptoms, ranging from seizures and focal neurological deficits to encephalopathy, cognitive impairment, and coma. This narrative review synthesises current evidence published between 2000 and 2025 regarding the pathophysiology, clinicopathological features, diagnostic approaches, and management strategies of major neuroparasitic diseases, including cerebral malaria, neurocysticercosis, neurotoxoplasmosis, human African trypanosomiasis, and amoebic encephalitis. Emphasis is placed on integrating clinical presentation with histopathological and neuroimaging findings to support diagnostic reasoning and therapeutic decision-making. Advances in diagnostic methodologies, including molecular techniques, magnetic resonance imaging, and computed tomography are discussed, alongside emerging perspectives on the potential role of artificial intelligence (AI) in diagnostic support and epidemiological modelling. By consolidating dispersed evidence into a unified framework, this review aims to serve as an educational and interdisciplinary reference for clinicians and researchers encountering neuroparasitic diseases in neurological practice.
- Open Access
- 5 December 2025
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 16 (4) , 295-308
Neurological Implications of T.gondii and the Role of Artificial Intelligence in Parasitic Psychiatry
Toxoplasma gondii (T.gondii), a protozoan parasite with global prevalence, shows a unique neurotropism that allows it to persist chronically within the central nervous system (CNS). While often clinically silent, chronic toxoplasmosis has been increasingly associated with a range of psychiatric conditions, including schizophrenia, bipolar disorder, suicidal behaviour, and potentially Alzheimer’s disease. The underlying mechanisms are multifactorial,involving direct cyst localization, neuroinflammation, altered neurotransmission, and immunomodulation. In parallel, artificial intelligence (AI) and machine learning (ML) tools are transforming the landscape of biomedical research. In the context of T. gondii, these tools are being employed in neuroimaging analysis, behavioural prediction models, and systems-level simulation of brain-parasite interactions. AI has the potential to enhance early detection of neuroanatomical changes, predict psychiatric outcomes based on infection markers, and uncover latent patterns in large-scale datasets. This descriptive review aims to synthesize the current knowledge on the neurological effects of T. gondii infection while highlighting the emerging integration of AI methodologies in parasitic neuroscience. We discuss pathophysiological mechanisms, psychiatric implications, and how computational tools may bridge gaps in understanding this enigmatic pathogen’s impact on the human brain.
- 5 December 2025
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 16 (4) , 295-308
Open AccessNeurological Implications of T.gondii and the Role of Artificial Intelligence in Parasitic Psychiatry
Toxoplasma gondii (T.gondii), a protozoan parasite with global prevalence, shows a unique neurotropism that allows it to persist chronically within the central nervous system (CNS). While often clinically silent, chronic toxoplasmosis has been increasingly associated with a range of psychiatric conditions, including schizophrenia, bipolar disorder, suicidal behaviour, and potentially Alzheimer’s disease. The underlying mechanisms are multifactorial,involving direct cyst localization, neuroinflammation, altered neurotransmission, and immunomodulation. In parallel, artificial intelligence (AI) and machine learning (ML) tools are transforming the landscape of biomedical research. In the context of T. gondii, these tools are being employed in neuroimaging analysis, behavioural prediction models, and systems-level simulation of brain-parasite interactions. AI has the potential to enhance early detection of neuroanatomical changes, predict psychiatric outcomes based on infection markers, and uncover latent patterns in large-scale datasets. This descriptive review aims to synthesize the current knowledge on the neurological effects of T. gondii infection while highlighting the emerging integration of AI methodologies in parasitic neuroscience. We discuss pathophysiological mechanisms, psychiatric implications, and how computational tools may bridge gaps in understanding this enigmatic pathogen’s impact on the human brain.